XRTX
Xyratex Ltd.
NASDAQ · Healthcare · Biotechnology · CA
$1.01
−18.55%Institutional positioning
13F filings over the trailing two quarters
New 6Increased 0Reduced 1Sold out 1
| Filer | Action | Shares | Filed |
|---|---|---|---|
| CITADEL ADVISORS LLC | New Position | 23,116 | Sep 2, 2026 |
| StoneX Group Inc. | New Position | 16,369 | Aug 12, 2026 |
| ROYAL BANK OF CANADA | New Position | 732 | Aug 14, 2026 |
| NATIONAL BANK OF CANADA /FI/ | New Position | 162 | Aug 10, 2026 |
| Clearstead Advisors, LLC | New Position | 55 | Aug 6, 2026 |
| TD WATERHOUSE CANADA INC. | New Position | 47 | May 12, 2026 |
| TD Waterhouse Canada Inc. | Reduced | 9 | Jul 27, 2026 |
| TD Waterhouse Canada Inc. | Sold Out | 0 | Jul 27, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings